ATP5PDP3: A Potential Drug Target and Biomarker (G138864)

Target Name: ATP5PDP3

NCBI ID: G138864

Other Name(s): ATP5HP3 | LOC138864 | ATP synthase peripheral stalk subunit d pseudogene 3 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d pseudogene

ATP5PDP3: A Potential Drug Target and Biomarker

ATP5PDP3, also known as ATP5HP3, is a protein that is expressed in various tissues and cells in the human body. It is a key regulator of the DNA damage response pathway, which is a critical pathway that helps maintain cellular health and homeostasis. Mutations in the DNA damage response pathway have been linked to a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Recent studies have identified ATP5PDP3 as a potential drug target and biomarker for a variety of diseases. In this article, we will explore the biology of ATP5PDP3, its potential drug targets, and its role as a biomarker for disease.

The Biology of ATP5PDP3

ATP5PDP3 is a 21-kDa protein that is expressed in various tissues and cells in the human body. It is primarily localized to the nuclei of cells and is involved in the regulation of DNA damage repair, DNA replication, and apoptosis.

ATP5PDP3 is a key regulator of the DNA damage response pathway. It is involved in the formation of the DNA double helix, which is a critical step in the DNA damage response pathway. When DNA is damaged, ATP5PDP3 helps to ensure that the double helix is properly repaired. It also helps to ensure that the damaged DNA is properly degraded and removed, which is critical for maintaining cellular health and homeostasis.

Mutations in the DNA damage response pathway have been linked to a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Studies have shown that alterations in ATP5PDP3 levels or function can have a significant impact on disease risk. For example, studies have shown that individuals with certain genetic mutations, such as those in the TP53 gene, are at increased risk for cancer.

Potential Drug Targets

ATP5PDP3 is a protein that has potential as a drug target for a variety of diseases. One of the most promising potential drug targets for ATP5PDP3 is the inhibition of its function. This can be achieved through a variety of methods, including inhibition of ATP5PDP3 activity with small molecules or antibodies, or through modulation of ATP5PDP3 expression levels.

In addition to inhibition of its function, ATP5PDP3 has also been identified as a potential drug target for its role in the DNA damage response pathway. Drugs that can modulate ATP5PDP3 expression levels or activity have the potential to be used to treat a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

Biomarkers

ATP5PDP3 has also been identified as a potential biomarker for a variety of diseases. Its expression levels can be used as a biomarker for diseases that are associated with altered DNA damage response, such as cancer, neurodegenerative diseases, and cardiovascular diseases.

In addition to its use as a biomarker, ATP5PDP3 has also been shown to be a potential therapeutic target for a variety of diseases. Its function in the DNA damage response pathway has been shown to be involved in the regulation of cellular processes that are critical for maintaining health and homeostasis. This suggests that modulation of ATP5PDP3 function may be a promising therapeutic approach for a wide range of diseases.

Conclusion

In conclusion, ATP5PDP3 is a protein that has potential as a drug target and biomarker for a variety of diseases. Its function in the DNA damage response pathway makes it an attractive target for the development of new therapies for cancer, neurodegenerative diseases, and cardiovascular diseases. Further research is needed to fully understand the biology of ATP5PDP3 and its potential as a drug

Protein Name: ATP Synthase Peripheral Stalk Subunit D Pseudogene 3

More Common Targets